These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7269869)

  • 1. [Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)].
    Opri F; Kirchner H
    Zentralbl Gynakol; 1981; 103(10):564-8. PubMed ID: 7269869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of CEA in benign breast disease (author's transl)].
    Opri F; Kirchner H; Mayfeld K
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
    Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
    Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
    Agbedana EO; Ebesunun MO
    Afr J Med Med Sci; 1998; 27(1-2):65-9. PubMed ID: 10456133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
    Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
    Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acid phosphatase activity in breast dysplasias and in carcinomas of the breast].
    Panazzolo A; Verna L; Cacciari P; Massobrio M; Frea F
    Arch Sci Med (Torino); 1976; 133(1):12-36. PubMed ID: 184755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of hydrolytic enzyme activities in breast cancer].
    Vierbuchen M; Würz H; Fischer R
    Verh Dtsch Ges Pathol; 1985; 69():131-4. PubMed ID: 4096102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of carcino-embryonic antigen and beta2-microglobulin. Methodological study and clinical interpretation (author's transl)].
    Depierre A; Kadouche J; Chamagne AM; Najean Y
    Pathol Biol (Paris); 1978 Sep; 26(6):341-2. PubMed ID: 83578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA positivity in tissue and sera of patients with benign breast lesions.
    Wittekind C; Von Kleist S; Sandritter W
    Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
    Wurster K; Heberling D; Rapp W
    Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of benign tumors and mammary dysplasias in cancerogenesis as related to lysosomal alpha-arylsulfatase and beta-glucoronidase enzyme activity].
    De Sanso G; Bracco G; Tanferna M; Graffino W; Panazzolo A
    Minerva Ginecol; 1981; 33(2-3):185-96. PubMed ID: 6265834
    [No Abstract]   [Full Text] [Related]  

  • 16. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
    Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor antigens in the diagnosis of gastroenterological diseases (author's transl)].
    Lehmann FG
    Leber Magen Darm; 1975 Aug; 5(4):144-58. PubMed ID: 57561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.
    Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J
    Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.